- Home
- TENX vs RDHL Comparison
TENX vs RDHL Comparison
Compare TENX & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- RDHL
- Stock Information
- Founded
- TENX 1967
- RDHL 2009
- Country
- TENX United States
- RDHL Israel
- Employees
- TENX N/A
- RDHL N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- TENX Health Care
- RDHL Health Care
- Exchange
- TENX Nasdaq
- RDHL Nasdaq
- Market Cap
- TENX 27.3M
- RDHL 3.9M
- IPO Year
- TENX N/A
- RDHL N/A
- Fundamental
- Price
- TENX $6.25
- RDHL $1.70
- Analyst Decision
- TENX Strong Buy
- RDHL
- Analyst Count
- TENX 4
- RDHL 0
- Target Price
- TENX $16.67
- RDHL N/A
- AVG Volume (30 Days)
- TENX 47.8K
- RDHL 43.1K
- Earning Date
- TENX 11-12-2025
- RDHL 09-05-2025
- Dividend Yield
- TENX N/A
- RDHL N/A
- EPS Growth
- TENX N/A
- RDHL N/A
- EPS
- TENX N/A
- RDHL N/A
- Revenue
- TENX N/A
- RDHL $9,550,000.00
- Revenue This Year
- TENX N/A
- RDHL $381.91
- Revenue Next Year
- TENX N/A
- RDHL N/A
- P/E Ratio
- TENX N/A
- RDHL N/A
- Revenue Growth
- TENX N/A
- RDHL 157.62
- 52 Week Low
- TENX $3.25
- RDHL $1.06
- 52 Week High
- TENX $7.89
- RDHL $11.70
- Technical
- Relative Strength Index (RSI)
- TENX 64.21
- RDHL 63.39
- Support Level
- TENX $6.02
- RDHL $1.47
- Resistance Level
- TENX $6.25
- RDHL $1.60
- Average True Range (ATR)
- TENX 0.15
- RDHL 0.09
- MACD
- TENX 0.03
- RDHL 0.04
- Stochastic Oscillator
- TENX 58.33
- RDHL 97.98
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.